Related references
Note: Only part of the references are listed.HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
Lasse Ramsgaard et al.
PLOS ONE (2011)
The role of receptor for advanced glycation endproducts (RAGE) in infection
Marieke Ad van Zoelen et al.
CRITICAL CARE (2011)
Phosphorylation of threonine 154 in p40phox is an important physiological signal for activation of the neutrophil NADPH oxidase
Tamara A. M. Chessa et al.
BLOOD (2010)
Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis
Marieke A. D. van Zoelen et al.
CRITICAL CARE MEDICINE (2010)
Exposure to Hydrogen Peroxide Induces Oxidation and Activation of AMP-activated Protein Kinase
Jaroslaw W. Zmijewski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis
Sami Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Receptor for Advanced Glycation End Products Facilitates Host Defense during Escherichia coli-Induced Abdominal Sepsis in Mice
Marieke A. D. van Zoelen et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production
Emmanuel Lorne et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury
Jaroslaw W. Zmijewski et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2008)
HMGB1 develops enhanced binding to cytokines
Yonggang Sha et al.
JOURNAL OF IMMUNOLOGY (2008)
Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase
Kazuhiro Omori et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Exposure to hydrogen peroxide diminishes NF-κB activation, IκB-α degradation, and proteasome activity in neutrophils
Jaroslaw W. Zmijewski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium
Ke Zen et al.
JOURNAL OF IMMUNOLOGY (2007)
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
De Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis
Derek C. Angus et al.
CRITICAL CARE MEDICINE (2007)
Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice
Rosemarijn Renckens et al.
JOURNAL OF IMMUNOLOGY (2006)
A specific p47phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites
Pham My-Chan Dang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
IE Dumitriu et al.
JOURNAL OF IMMUNOLOGY (2005)
Myeloperoxidase: friend and foe
SJ Klebanoff
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Activation and assembly of the NADPH oxidase: a structural perspective
Y Groemping et al.
BIOCHEMICAL JOURNAL (2005)
Reactivity of 2′,7′-dichlorodihydrofluorescein and dihydrorhodamine 123 and their oxidized forms toward carbonated nitrogen dioxide, and hydroxyl radicals
M Wrona et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Chronic granulomatous disease
PG Heyworth et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism
PV Vignais
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
A Bierhaus et al.
DIABETES (2001)
The biology of the receptor for advanced glycation end products and its ligands
AM Schmidt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)